Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Delirium common after hospital discharge in critically ill COVID-19 patients

Anesthesiologist and other researchers from Michigan Medicine, Ann Arbor, New York Medical College, Valhalla and Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, have reported a case series of critically ill coronavirus disease 2019 (COVID-19) patients who have developed neuropsychological symptoms after having been discharged from the hospital.

8 Nov 2020

Biologic or targeted synthetic DMARDs reduce dementia in patients with rheumatoid arthritis

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.

6 Nov 2020

Study: Genetically edited form of herpes simplex virus outperforms leading vaccine candidate

A genetically edited form of a herpes simplex virus -- rewired to keep it from taking refuge in the nervous system and eluding an immune response -- has outperformed a leading vaccine candidate in a new study from the University of Cincinnati, Northwestern University and the University of Nebraska-Lincoln.

6 Nov 2020

Persistent and extensive lung damage seen in COVID-19 patients

A team of researchers at the University of Trieste in Italy aimed to determine the extent and the causes of lung damage from COVID-19 to better understand the pathological correlates of the disease.

5 Nov 2020

Researchers gain novel insights into the role of autophagy in neurons

It appears that autophagy protects our neurons in the brain, but evidently for entirely different reasons than previously assumed, as researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Charité in Berlin have now shown.

5 Nov 2020

HKUST researchers identify new therapeutic targets for Alzheimer's disease

Researchers at the Hong Kong University of Science and Technology have identified new therapeutic targets for Alzheimer's disease (AD) by studying the patients' brain with a newly-developed methodology.

5 Nov 2020

NIH awards grant totaling $19.5M for Down syndrome research project

Scientists and data experts are joining forces to create the world's first centralized platform for Down syndrome researchers to share, access, and analyze data.

5 Nov 2020

Cleveland Clinic receives $2.6 million NIA grant to develop automated screening for cognitive decline

Cleveland Clinic has been awarded a $2.6 million grant from the National Institute on Aging to develop and validate two automated tools - a risk calculator to identify patients at high risk of cognitive decline and a screening tool to test for cognitive decline.

5 Nov 2020

Neuroscientists receive ERC Synergy Grant to explore the neural basis of cognition

A Norwegian-Israeli team of neuroscientists has been awarded an ERC Synergy Grant to explore the biological basis of spatial operations in the brain.

5 Nov 2020

Novel insights on a common protein could have broad biomedical applications

A new University of Colorado Boulder-led study sheds light on a protein key to controlling how cells grow, proliferate and function and long implicated in tumor development.

4 Nov 2020

New treatment method could be more effective for Alzheimer's disease

In Alzheimer's disease, a protein (peptide) forms clumps in the brain and causes sufferers to lose their memory. In a recently published article, a research group at Uppsala University described a new treatment method that increases the body's own degradation of the building blocks that lead to these protein clumps.

3 Nov 2020

Researchers use new approach to study the mechanisms of cellular uptake of amyloid beta

One of the hallmarks of Alzheimer's disease is the formation of amyloid plaques--sticky clumps of a protein called amyloid beta--that collect between neurons in the brain.

3 Nov 2020

New articles focus on policy considerations for post-COVID presidency

The Gerontological Society of America's highly cited, peer-reviewed journals are continuing to publish scientific articles on COVID-19.

3 Nov 2020

Root bacterium could provide a new approach for treatment of Alzheimer's

A bacterium found among the soil close to roots of ginseng plants could provide a new approach for the treatment of Alzheimer's.

2 Nov 2020

Novel MRI contrast agent offers hope for early detection of Alzheimer’s disease

Hong Kong Baptist University scientists have invented a novel contrast agent for magnetic resonance imaging, which enables real-time visualization and detection of the size and number of amyloid-beta in the brain, a main hallmark of Alzheimer’s disease.

2 Nov 2020

Beetroot peptide may be a good candidate for development of a drug to treat inflammatory diseases

In a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule) from beetroot.

30 Oct 2020

The road to achieving single molecular spectroscopy using nanoIR

In this interview, Francesco Simone Ruggeri from the University of Cambridge talks to News-Medical Life Sciences about their research into biomolecules and the methods that are helping to achieve spectra at the single-molecule scale.

From Bruker Nano Surfaces and Metrology 30 Oct 2020

SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

Like a key, SARS-CoV-2 - the virus that causes coronavirus disease 2019 (COVID-19) - attaches to specific molecules on the host cell surface, opening gateways into the cell interior.

30 Oct 2020

Study shows statins can have adverse effects on certain organs

600,000 Danes take medicine containing statins. Statins lower the cholesterol level and thus helps prevent cardiovascular disease and blood clots.

30 Oct 2020

Researchers identify distinct link between autism and brain cell abnormalities

Johns Hopkins Medicine researchers report that new experiments with genetically engineered mice have found clear connections among a range of autism types and abnormalities in brain cells whose chemical output forges platonic (non-sexual) feelings of love and sociability.

30 Oct 2020